MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Clinical and neuroimaging heterogeneity of dementia with Lewy bodies

    A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russian Federation)

    Objective: To study clinical and neuroimaging features of dementia with Lewy bodies (DLB) for optimal management and prognosis of the disease. Background: Appropriate diagnosis of DLB…
  • 2019 International Congress

    Validation of the Seoul-instrumental activity daily living in the detection of dementia in Parkinson disease

    SJ. Kim (Busan, Republic of Korea)

    Objective: The Seoul-instrumental activity of daily living (S-iADL) scale is well known to the tool for instrumental activities of Korean elders. However, the cutoff point…
  • 2019 International Congress

    Pisa syndrome in Parkinson’s disease: a study on the neuropsychological profile.

    E. Montanaro, CA. Artusi, S. Tuttobene, A. Romagnolo, M. Zibetti, L. Lopiano (Torino, Italy)

    Objective: To evaluate whether Pisa syndrome (PS) in Parkinson’s disease (PD) is associated with a specific profile of cognitive impairment. Background: PS is a complex…
  • 2019 International Congress

    Cognitive impairment in Parkinson’s Disease: A cross-sectional association study

    A. Simon, C. Rodriguez-Blazquez, MJ. Forjaz, P. Martinez-Martin (Madrid, Spain)

    Objective: To characterize the presence and clinical presentation of PD-MCI and PDD in patients with idiopathic PD, examining motor and non-motor features and determining factors…
  • 2019 International Congress

    Effect of global cognitive score on motor and quality of life outcomes after deep brain stimulation in patients with Parkinson’s disease or essential tremor

    E. Staikova, D. Loring, M. Delong, S. Triche, C. Buetefisch, C. Esper, T. Wichmann, L. Scorr, L. Higginbotham, P. Aia, S. Factor, S. Miocinovic (Atlanta, GA, USA)

    Objective: To determine if preoperative global cognitive score, Mattis Dementia Rating Scale 2nd Edition (DRS-2), predicts motor and quality of life (QoL) outcomes in patients…
  • 2019 International Congress

    Functional MRI activation during the Symbol Digit Modalities Test in Parkinson’s disease

    G. Grolez, R. Viard, R. Lopes, JP. Pruvo, K. Dujardin, L. Defebvre, C. Moreau (Lille, France)

    Objective: To assess alterations in functional brain activation patterns related to mental slowing in patients with Parkinson’s disease (PD). Background: Attentional deficits, namely mental slowing,…
  • 2019 International Congress

    Comorbidities and medications in Huntington’s disease, Parkinson’s disease and the general population in a US claims database

    L. Ishihara, E. Wild, D. Oliveri (Welwyn Garden City, United Kingdom)

    Objective: This study characterises the comorbidities and symptoms, and treatment patterns of patients with Huntington’s disease (HD) vs patients with Parkinson’s disease (PD) vs the…
  • 2019 International Congress

    Are Cognitive Changes in Hereditary Spastic Paraplegias Restricted to Complicated Forms?

    L. Jacinto-Scudeiro, G. Machado, A. Ayres, D. Burguêz, M. Polese-Bonatto, C. González-Salazar, M. Siebert, M. França Jr, M. Olchik, J. Saute (Porto Alegre, Brazil)

    Objective: We aimed to characterize cognitive functions of patients with pure and complicated HSP, and to determine the frequency of abnormal cognitive performances in the…
  • 2019 International Congress

    Metabolic syndrome and insulin resistance in Parkinson’s disease: could they affect motor or cognitive symptoms?

    M. Hussein, A. Khamis, R. Soliman, S. Ali (Beni Suef, Egypt)

    Objective: The objective of this work was to detect the markers of metabolic syndrome and insulin resistance in patients with PD and to study their…
  • 2019 International Congress

    Predicting domain specific cognitive impairment in Parkinson’s disease

    P. Zarifkar, J. Kim, C. La, P. Borghammer, K. Poston (Palo Alto, CA, USA)

    Objective: To investigate whether between-hippocampal connectivity and CSF proteins can predict domain-specific cognitive impairment in Parkinson’s disease (PD). Background: Cognitive dysfunction is a common and…
  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley